Innate Pharma presents proprietary antibody-drug conjugate technology at the World ADC Summit in San Francisco
New site-specific conjugation technology for homogenous antibody-drug conjugates (ADCs) Provides further opportunities for portfolio expansion and partnering Innate Pharma SA (the “Company” - Euronext...